Glial Lipid Droplets and ROS Induced by Mitochondrial Defects Promote Neurodegeneration  by Liu, Lucy et al.
ArticleGlial Lipid Droplets and ROS Induced
by Mitochondrial Defects
Promote Neurodegeneration
Lucy Liu,1 Ke Zhang,2,10 Hector Sandoval,3 Shinya Yamamoto,3,4,5 Manish Jaiswal,3,6 Elisenda Sanz,7 Zhihong Li,3
Jessica Hui,8 Brett H. Graham,3 Albert Quintana,7,8,9 and Hugo J. Bellen1,2,3,4,5,6,*
1Department of Neuroscience, Baylor College of Medicine, Houston, TX 77030, USA
2Structural and Computational Biology & Molecular Biophysics Graduate Program, Baylor College of Medicine, Houston, TX 77030, USA
3Department of Molecular and Human Genetics, Baylor College of Medicine, Houston, TX 77030, USA
4Program in Developmental Biology, Baylor College of Medicine, Houston, TX 77030, USA
5Jan and Dan Duncan Neurological Research Institute at Texas Children’s Hospital, Houston, TX 77030, USA
6Howard Hughes Medical Institute, Baylor College of Medicine, Houston, TX 77030, USA
7Center for Integrative Brain Research, Seattle Children’s Research Institute, Seattle, WA 98101, USA
8Center for Developmental Therapeutics, University of Washington, Seattle, WA, 98195, USA
9Department of Pediatrics, University of Washington, Seattle, WA, 98195, USA
10Present address: Department of Neurology, Johns Hopkins University School of Medicine, Baltimore, MD 21205, USA
*Correspondence: hbellen@bcm.edu
http://dx.doi.org/10.1016/j.cell.2014.12.019SUMMARY
Reactive oxygen species (ROS) and mitochondrial
defects in neurons are implicated in neurodegenera-
tive disease. Here, we find that a key consequence
of ROS and neuronal mitochondrial dysfunction is
the accumulation of lipid droplets (LD) in glia. In
Drosophila, ROS triggers c-Jun-N-terminal Kinase
(JNK) and Sterol Regulatory Element Binding Protein
(SREBP) activity in neurons leading to LD accumula-
tion in glia prior to or at the onset of neurodegenera-
tion. The accumulated lipids are peroxidated in the
presence of ROS. Reducing LD accumulation in glia
and lipid peroxidation via targeted lipase overexpres-
sion and/or lowering ROS significantly delays the
onset of neurodegeneration. Furthermore, a similar
pathway leads to glial LD accumulation in Ndufs4
mutant mice with neuronal mitochondrial defects,
suggesting that LD accumulation following mito-
chondrial dysfunction is an evolutionarily conserved
phenomenon, and represents an early, transient indi-
cator and promoter of neurodegenerative disease.
INTRODUCTION
Many neurodegenerative diseases are characterized by a
gradual demise of neurons, coupled with a reduction in antioxi-
dative capacity and/or an increase in oxidative stress (Turner
et al., 2009; Gilgun-Sherki et al., 2001; Lin and Beal, 2006; Keller
et al., 2005). Oxidative stress may result from impaired mito-
chondrial function and/or glutamate excitotoxicity and causes
DNA and protein damage as well as lipid peroxidation (Niki,
2009; Reed, 2011). These stresses promote damage to neurons
and glia and contribute to the demise of neurons (Barnham et al.,2004; Listenberger et al., 2003). In the cell, complexes I and III
of the mitochondrial electron transport chain are the major con-
tributors of free radicals and ROS (Beal, 2007). Importantly, signs
of oxidative stress precede the neurological signs of neurode-
generation (ND) in disease models (Pratico` et al., 2001; Keller
et al., 2005; Xie et al., 2013).
Lipid droplets (LDs) are dynamic organelles that emerge from
the endoplasmic reticulum (ER) membrane and serve as a site of
triglyceride and cholesterol storage. Under normal conditions,
LDs are mostly found in liver and adipose tissues and actively
respond to cellular signaling (Murphy, 2001; Farese andWalther,
2009). One important regulator of LD biogenesis is sterol regula-
tory element binding protein (SREBP), a highly conserved, mem-
brane-bound, basic helix-loop-helix leucine zipper transcription
factor that is crucial for lipid homeostasis (Horton et al., 2002).
SREBP regulates lipogenesis and responds to levels of sterols
in mammals and palmitate in Drosophila, respectively (Shao
and Espenshade, 2012; Dobrosotskaya et al., 2002). Impor-
tantly, Drosophila SREBP mutants are auxotrophs, and SREBP
levels are critical in larval stages (Kunte et al., 2006). Inactive
SREBP is a transmembrane protein located in the ERmembrane
which relocates to the Golgi upon activation where it forms a
complex with SREBP-cleavage activating protein (SCAP) (Hor-
ton et al., 2002). In the Golgi, SREBP is cleaved by site-1 and
site-2 proteases to generate active SREBP. Active SREBP is
then translocated into the nucleus and promotes transcription
of genes involved in lipid metabolism (Shao and Espenshade,
2012). Although SREBP expressed in the gut responds to levels
of circulating lipids and cholesterol, the blood-brain-barrier pre-
vents lipids from entering the brain inmammals and de novo lipo-
genesis is critical for nervous system function (Camargo et al.,
2009). Though the Drosophila nervous system can incorporate
lipids from the gut, brain triacylglycerol levels are protected un-
der stress and starvation (Palm et al., 2012; Cheng et al., 2011).
Cells other than adipocytes can form LDs as a response to
cellular inflammation and stress (Santos and Schulze, 2012). InCell 160, 177–190, January 15, 2015 ª2015 Elsevier Inc. 177
cancer cells, LDs are hypothesized to be an important source of
energy for proliferation and may serve a protective role under
conditions of hypoxia and cellular stress by gathering free fatty
acids to protect cells against lipotoxicity (Bozza and Viola,
2010). However, ND has typically not been associated with LD
formation in the nervous system, although few mouse mutants
have been documented to have LDs in the brain (Mato et al.,
1999; Hulshagen et al., 2008; Wang et al., 2002). Finally, lipid
metabolism defects have been implicated in some forms of
ALS (Ilieva et al., 2009; Turner et al., 2009; Pratico` et al., 2001),
but not other neurodegenerative diseases.
In this study, we document that ROS induced LD accumula-
tion presages ND in several Drosophila mutants affecting mito-
chondrial function. We describe a ROS-activated pathway in
neurons, which induces LD formation in glia in a cell non-auton-
omous fashion. Reducing LD accumulation is sufficient to delay
ND. Finally, we find that the LD accumulation also occurs in
mice with mitochondrial dysfunction, suggesting that LD for-
mation upon oxidative stress is an evolutionarily conserved
phenomenon.
RESULTS
Mitochondrial Mutants Exhibit Lipid Droplet
Accumulation in Glia
We previously performed forward genetic mosaic screens of
essential genes in theDrosophila visual system to uncover genes
that cause ND of photoreceptors (Yamamoto et al., 2014). While
characterizing the phenotypes by transmission electron micro-
scopy (TEM) in the retina and brain, we found structures reminis-
cent of LDs. In Drosophila, photoreceptors (neurons) project
their axons directly into the brain and form synapses with post-
synaptic neurons. Pigment cells (glia) ensheath the photore-
ceptor cell body in the retina and epithelial glia ensheath their
axonal terminals (Edwards and Meinertzhagen, 2010). We found
that three different mutants, sicily (Zhang et al., 2013), Aats-met
(Bayat et al., 2012), andMarf (Sandoval et al., 2014) exhibit abun-
dant LD accumulations in pigment (Figures 1A–1C) and epithelial
glia (Figures S1A–S1C).
These three fly genes play important but distinct roles in mito-
chondrial biology and mutations in the human homologs cause
neurological diseases. sicily is the homolog of the human
nuclear encoded mitochondrial gene NDUFAF6 (C8orf38). Its
loss leads to an early onset neurodegenerative disease known
as Leigh syndrome (Pagliarini et al., 2008). sicily functions as a
chaperone for Complex I proteins and its loss leads to severe
mitochondrial dysfunction (Zhang et al., 2013; McKenzie
et al., 2011).Marf encodes the Drosophila homolog of the mito-
chondrial fusion GTPase, Mitofusin 1 and 2 (Debattisti and
Scorrano, 2013). Mutations in MFN2 cause Charcot-Marie-
Tooth disease type 2A2 (CMT2-A2), an autosomal dominant
adult onset peripheral neuropathy (Kijima et al., 2005) as
well as Hereditary motor and sensory neuropathy VI (HMSN6)
(Del Bo et al., 2008). Lastly, Aats-met is the Drosophila homolog
of mitochondrial methionyl-tRNA synthetase 2, or MARS2.
Proteins encoded by these genes mediate the transfer of
methionine to their cognate tRNA in the mitochondria matrix.
Mutations in MARS2 lead to a disease known as autosomal178 Cell 160, 177–190, January 15, 2015 ª2015 Elsevier Inc.recessive spastic ataxia with leukoencephalopathy (ARSAL)
(Thiffault et al., 2006; Bayat et al., 2012).
Transmission electron micrographs of 1-day-old wild-type
retinal clones show the stereotypical organization of photore-
ceptors in each ommatidium (Figure 1A a). Each ommatidium
is separated by thin pigment cells (Figures 1A a and 1B, pseudo-
colored in blue). Loss of sicily, Aats-met orMarf leads to an accu-
mulation of LDs (arrow) in glia (Figures 1A a–d and 1C), which is
not observed in controls. Importantly, LDs are not observed in
photoreceptors. In addition to the retina, LDs also accumulate
in the epithelial glia of the lamina (Figure S1A a-d, S1B, and
S1C). In summary, LD-like structures are present in cells that
function as glia but not in neurons.
To determine whether the structures seen in Figure 1 are
indeed LDs, we created large mutant clones in the visual sys-
tem by GMR-hid (Stowers and Schwarz, 1999) and observed
LD accumulation in the glia in sicily, Marf, and Aats-met
mutants using Nile Red (Figure 1D a–d) and BODIPY493/503
(Figure S1D), (Greenspan et al., 1985; Pavlopoulos et al.,
1990). The rhabdomeres (dashed white) are also labeled and
serve as reference point for each ommatidium. sicily, Aats-
met and Marf clones show LD accumulation in the area where
the glia are located, whereas control animals do not show stain-
ing (Figure 1E). In summary, mutations in genes involved in
three separate mitochondrial processes, Complex I activity,
fusion, and protein translation, exhibit LD accumulations in
the glia of newly eclosed adults prior to the onset of ND. How-
ever, not all mitochondrial mutations cause LD accumulation
(see below).
The morphology of sicily, Aats-met, and Marf photoreceptors
is mostly normal or only mildly affected at day 1 based on TEM
(Figure 1A). They begin to degenerate several days after eclosion
and the process occurs faster in sicily and Marf mutants than in
Aats-met mutant clones (Figure S1E) as revealed by fluores-
cently conjugated phalloidin labeling of actin rich rhabdomeres.
Elongated or diffuse rhabdomeres are characteristic for mutants
that cause a progressive photoreceptor degeneration (Xiong and
Bellen, 2013).
Lipid Droplets Accumulate Transiently in Glia
Next, we sought to characterize the temporal nature of the LD
accumulation phenotype. One-day-old sicily, Aats-met and
Marf clones exhibit approximately 10 LD per ommatidium.
Upon aging, we noticed a significant decrease in the number
of LD in the mutant clones (Figures S2A a–i, j–l and S2B), indi-
cating that LD accumulation occurs prior to or concurrent with
the onset of ND and is a transient phenomenon (Figure S2C).
Increased ROS Correlates with Increased LD
Accumulation
Since sicily,Aats-met, andMarf affectmitochondrial function, we
sought to investigate the potential link between LD accumulation
and mitochondrial dysfunction for other nuclear encoded mito-
chondrial genes. We knocked down ND42, a CI subunit that is
chaperoned by sicily (Zhang et al., 2013) and parkin, an E3 ubiq-
uitin ligase involved in mitochondrial clearance using RNAi.
Whole-eye knockdown of both ND42 and parkin leads to LD
accumulation (Figure S3A a and b and Figure 1E). However,
Figure 1. LD Accumulate in Glia of Mito-
chondrial Mutants with Elevated Levels of
Reactive Oxygen Species
TEM of a single ommatidium of 1-day-old flies.
(A) a, Pigment cells that surround the photore-
ceptors are typically very thin (blue) in wild-type
eyes (y w FRT19A clones). They are vastly
expanded in b, sicily, c, Aats-met, and d, Marf
mutants and contain numerous LD (red arrow-
head).
(B) Schematic of a single ommatidium in cross-
section.
(C) Quantification of retina LD per ommatidium.
(D) a–d, Nile Red stained whole-mount retina show
LD accumulation (white arrowhead) in sicily, Marf,
and Aats-metmutant clones of 1-day-old flies, but
not in controls (y w FRT19A clones). Rhabdomeres
outlined in white. Abnormal rhabdomere
morphology can be seen in sicily andMarf mutant
clones.
(E) Quantification of LD per ommatidium of (D). A
minimum of 16 eyes were stained and approxi-
mately 36 ommatidia were quantified.
(F) Aconitase activity is used to measure ROS -
before and after enzymatic reactivation with
reducing agents. RNAis were driven by the ubiq-
uitously expressed daughterless[da]-GAL4.
(G) Correlation between aconitase enzymatic ac-
tivity and LD per ommatidium. R = correlation
coefficient. Data are represented as mean ± SEM.
See also Figures S1, S2, and S3.escapers of Pink15 (which encodes amitochondrial kinase; Clark
et al., 2006) do not exhibit LD accumulation (Figure S3A c and
Figure 1E). In addition, retinal clones of Drp12, which encodes
a protein involved in mitochondria fission (Verstreken et al.,
2005), also do not result in LD accumulation (Figure S3A d and
Figure 1E). The presence of LD accumulations in a subset of
mitochondrial mutants suggests that the loss of these genes
share a common pathway.
Previously, we noticed elevated levels of reactive oxygen
species (ROS) in sicily, Marf, and Aats-met mutants (Zhang
et al., 2013; Bayat et al., 2012; Sandoval et al., 2014). To deter-Cell 160, 177–190mine whether increased ROS production
and subsequent oxidative stress may
promote LD formation, we measured
aconitase enzymatic activity in third
instar larvae (Yan et al., 1997). Enzymatic
activity for aconitase is less than 50%
of wild-type activity in all three mutants
as well as ND42 and parkin RNAi
knockdown, documenting the presence
of high levels of ROS and possibly a
threshold effect. Moreover, aconitase
activity is less affected (more than
50% of wild-type activity) in Drp12 and
Pink15 mutants (Figure 1F). As shown in
Figure 1G, there is a strong correlation
between decreased aconitase enzymatic
activity and the number of LD per omma-tidium (R =0.82). These data suggest that ROSmay play a role
in LD accumulation.
Reducing ROS Ameliorates Lipid Droplet Accumulation
To establish a causative relationship between ROS and LD accu-
mulation, we employed pharmacologic and genetic methods
to reduce ROS and assessed LD. N-acetyl cysteine amide
(AD4) is a blood-brain-barrier penetrating antioxidant that can
decrease oxidative stress in vitro and in vivo (Schimel et al.,
2011; Amer et al., 2008). We administered AD4 via fly food at
concentrations of 20 mg/ml and 40 mg/ml (Bayat et al., 2012)., January 15, 2015 ª2015 Elsevier Inc. 179
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Figure 2. Antioxidants Reduce LD Accumu-
lation in Mutant Retinas
(A) a–c, Nile Red stains of 1-day-old sicily, Marf,
and Aats-met mutant retinas reveal LD accumu-
lation. d–f, Animals fed with AD4 at 40 mg/ml
(AD4high in quantification) reduces the number of
LD. Notice the partial restoration of rhabdomere
integrity inMarfmutants. g–i, Suppressing ROS by
overexpression of a copy of hSOD1 (eyeless[ey]-
Gal4, UAS-Flp) also reduces LD accumulations.
(B) Quantification of the data presented in (A) and
animals with mutant clones raised on food sup-
plemented with 20 mg/ml (AD4low) of AD4 the show
a reduction of LD accumulation.
(C) Linear regressions show a negative correlation
between the numbers of LD accumulated and the
amount of supplemented AD4.
(D) Expression of hSOD1 with da-Gal4 in sicily
mutants significantly suppresses the loss of aco-
nitase activity and hence ROS.
(E) Nile Red staining of wild-type (Canton-S) flies
show no LD accumulation whereas staining of
SODn1 mutant escapers reveal high levels of LD
accumulation.
(F) Quantification of SODn1 LD accumulation. Data
are represented as mean ± SEM. Significance was
calculated compared to controls using t tests (*p <
0.05, **p < 0.005, ***p < 0.0005).Compared to mutants raised in standard fly food (Figure 2A a–c),
animals raised on AD4 food (Figure 2A d–f) show a dose-depen-
dent reduction in LD accumulation (Figures 2B and 2C). In addi-180 Cell 160, 177–190, January 15, 2015 ª2015 Elsevier Inc.tion, we overexpressed human copper-
zinc superoxide dismutase (hSOD1), a
conserved antioxidative enzyme that
has been shown to rescue or extend
Drosophila lifespan (Parkes et al., 1998).
Overexpression of hSOD1 in mutant
larvae reduces ROS levels (Figure 2D)
and considerably suppresses the LD
accumulations in glia (Figure 2A g–i). To
further determine whether the presence
of ROS causes LD accumulation, we as-
sessed LD accumulation in SOD mutant
flies. SODn1 mutant (Sun et al., 2012)
glia also exhibit LD accumulations, similar
in levels to what we observe in Aats-met
clones (Figures 2E and 2F and 2B). In
summary, these results provide compel-
ling evidence that removing ROS reduces
LD accumulation and increasing ROS in-
duces LD accumulation.
Elevated ROS Promotes JNK/
SREBP Activation and Reducing
JNK/SREBPActivity Suppresses LD
Accumulation
Prolonged increase of ROS triggers a
stress response that is mediated by c-
Jun-N-terminal Kinase (JNK) signaling inboth Drosophila and mammals. JNK activates the transcription
of downstream genes, including its own inhibitor, JNK phospha-
tase. In Drosophila, JNK phosphatase is encoded by puckered
(puc), whose expression is used as readout for JNK activity (Mar-
tı´n-Blanco et al., 1998). ROS can suppress JNK phosphatase ac-
tivity and therefore allows sustained JNK activation (Kamata
et al., 2005).
Given the presence of LD, we assessed SREBP activity. To
determine whether JNK and SREBP are involved in the LD accu-
mulation observed in sicily, Aats-met and Marf clones, we
removed a copy of either JNK or SREBP in each mutant back-
ground. Removal of a single copy of either JNK or SREBP is suf-
ficient to ameliorate the LD accumulation in all three mutants
(Figures 3A and 3B). In addition, visual system (ey-GAL4) knock-
down of JNK in the sicily and Marf mutant background also
significantly reduces LD accumulation (Figures S4A and S4B).
Furthermore, JNK may be upstream of SREBP as the LD accu-
mulations caused by overexpressing JNK with a neuronal driver
in SREBP hemizygous (SREBP189/+) flies is strongly suppressed
(Figure S6C and quantified in Figure S6D) (Kunte et al., 2006).
To determine the extent of JNK upregulation in these mutants,
we first performed quantitative RT-PCR in all three mutant larvae
and observed an upregulation of puc (Figure 3C), suggesting
JNK activation. To determine whether JNK is elevated, we
used brain lysates from mutant larvae and immunoblotted
against total JNK and phosphorylated JNK (pJNK) and found
both to be elevated (Figure S4C). To further document a persis-
tent elevation of JNK, we performed immunoblots for total JNK in
adult headswithmutant eye clones. Althoughmost of the brain is
wild-type, much of the visual system is mutant. sicily, Aats-met,
andMarfmutants exhibit elevated levels of total JNK (Figure 3D),
yet only an estimated 40% of the loaded tissue is homozygous
mutant. These data indicate that JNK activation correlates with
ROS levels.
To test whether SREBP is upregulated in these mutants,
we immunoblotted protein extracted from mutant larvae and
observed a five-fold increase in level of active/cleaved SREBP
(Figure S4C). Mutants that do not exhibit LD accumulation do not
exhibit elevated levels (Pink15) or modest increases of SREBP
(Drp12) (Figure S4D). Furthermore, we observe an upregulation
of active SREBP as well as an upregulation of Acetyl CoA
carboxylase (ACC) in adult heads with mutant clones (Figure 3D),
whose transcription levels are directly regulated by SREBP
(Seegmiller et al., 2002). JNK is necessary for the activation of
SREBP (Figure 3D). Moreover, reducing ROS by overexpressing
hSOD1 in sicily mutant larvae decreases the levels of JNK and
active SREBP (Figure S4E). Finally, reducing ROS with AD4 re-
duces levels of active SREBP in mutant larvae (Figure S4C).
Our results therefore strongly indicate that ROS stimulates the
activation of JNK and SREBP and this axis directly contributes
to the LD accumulation phenotype in the nervous system.
Neuronal but Not Glial Mitochondrial Dysfunction
Induces Cell Non-Autonomous LD Accumulation in Glia
To determine the cell specific defects that lead to LD accumula-
tion, we knocked down Marf, Aats-met, and ND42 expression
with RNAi lines driven by a neuronal driver or pigment glia driver
(Bao et al., 2010). To demonstrate that the glial driver is able to
reduce the expression of genes in pigment cells we crossed it
to an RNAi against the white gene. As shown in Figure S5, the
54C-GAL4 driver efficiently reduces pigment levels.Neuronal expression of RNAi against Marf, Aats-met and
ND42 causes significant LD accumulation in glia but not neurons
(Figure 4A a–c and Figure 4B). However, RNAi in glia for these
genes does not result in LD accumulation (Figure 4A d–f and Fig-
ure 4B). Hence, neuronal knockdown of Marf, Aats-met and
ND42 is sufficient to lead to LD accumulation glia.
To assess if overexpression of JNK or SREBP is sufficient to
induce LD accumulation, we overexpressed JNK, Hemipterous
(theDrosophila JNK Kinase), or full-length SREBP using neuronal
or glia specific drivers. As shown in Figure 4C, neuronal expres-
sion of JNKor SREBP leads to glial cell specific LDaccumulation,
whereas glial cell specific expression did not. Activation of JNK is
required for the LD accumulation phenotype as overexpression
of JNKK also leads to LD accumulation. In summary, activation
of JNK or SREBP in neurons is sufficient to cause LD in glia.
It is interesting to note that neuronal overexpression of JNK or
SREBP alone does not cause ND upon aging (Figure S5B) and
LDs are retained in aged animals (data not shown). These data
show that glial LD accumulation is not sufficient to cause ND,
and additional insults are likely to be required.
Neuronal knockdown ofMarf, Aats-met, and ND42 leads to LD
accumulation in glia. To assess whether a reduction in ROS or
JNK in neurons alone is sufficient to reduce LD accumulation in
glia, we expressed Marf RNAi under the control of the photore-
ceptor specific Rhodopsin (Rh1) promoter (Rh-Marf RNAi).
Rh-Marf RNAi leads to LD accumulation in glia, but expression
of hSOD1 or reduction of JNK (RNAi) using a neuronal driver,
significantly reduce LD accumulation. However, when we reduce
JNK in glia, LDs are retained (Figures S7A and S7B). Hence,
elevated ROS and JNK activation in neurons is sufficient and
necessary to cause LD accumulation in glia, providing compelling
evidence that this neuronal pathway plays a critical role in LD
accumulation.
Reduction of LDs Delays Neurodegeneration
To assay ND in various genetic backgrounds, we assessed
degeneration as previously mentioned. Upon aging, mutant flies
exhibit a significant loss of f-actin staining in rhabdomeres when
compared to day 1 (Figure 5A a–f). To assaywhether reduction of
the levels of ROS, JNK, or SREBP suppress LD aswell as ND, we
analyzed the rhabdomere phenotypes of flies fed with 40 mg/ml
of AD4, overexpressing hSOD1, or lacking one copy of JNK or
SREBP, by phalloidin staining (Figure 5A g–r). These animals
contain significantly more intact rhabdomeres when aged
compared to mutants alone (Figure 5B). These data show that
suppression of ROS/JNK/SREBP suppress LD formation and
delays ND.
To determine whether reducing LD by ectopic expression of li-
pases are protective in ND, we expressed two different lipases in
mutant clones and assessed ND: Lipase 4 (Lip4), homolog of hu-
man acid lipases, functions in starvation mediated lipolysis, and
brummer, homolog of adipocyte triglyceride lipase (ATGL), local-
izes to the LD surface, and acts in lipolysis (Gro¨nke et al., 2005).
When we expressed the lipases in mutant clones, the expression
of either lipase partially restores the shape, density, and number
of identifiable rhabdomeres (Figure 5A s–x, and 5C), indicating
that reducing LD accumulation partially alleviates ND. This was
confirmed by TEM (Figure S5C).Cell 160, 177–190, January 15, 2015 ª2015 Elsevier Inc. 181
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Figure 3. ROS Leads to Aberrant Activation of JNK and SREBP and Reducing JNK or SREBP in Mutants Reduces LD Accumulation
(A) a–c, sicily, Aats-met and Marf mutant clones exhibit high levels of LD accumulation but when one copy of JNK (d–f) or SREBP (g–i) is removed, LD accu-
mulation is significantly reduced.
(B) Quantification of retinas in (A).
(C) qRT-PCR quantification of puc shows a significant upregulation of puc mRNA in all three mutant larvae compared to control (y w FRT19A).
(D) Immunoblot of sicily, Aats-met and Marf heads with mutant eye clones show an increase in ACC, total JNK and active SREBP when compared to control
(y w FRT19A). Knockdown of JNK in the sicily mutant background (heads), reduces active SREBP levels compared to heads with mutant visual systems.
Data are represented as mean ± SEM. Significance was calculated compared to controls and immunoblots were normalized to loading control (porin). (*p < 0.05,
**p < 0.005, ***p < 0.0005). See also Figure S4.
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Figure 4. Photoreceptor Neurons, but Not
Glia, Induce LD Accumulation Cell Non-
Autonomously
(A) a–c, Nile Red stains show that neuronal
knockdown (elav-GAL4) of Marf, Aats-met, and
ND42 result in LD accumulation in the glia. d–f,
Glial (54C-GAL4) knockdown of Marf, Aats-met,
and ND42 does not result in LD accumulation.
(B) Quantification of (A).
(C) a and e, Control (white) do not exhibit LD
accumulation. b–d, Overexpression of JNK, JNKK
and SREBP in the neurons (elav-GAL4) leads to LD
accumulation in the glia. e–h, However, over-
expression of JNK, JNKK and SREBP in the glia
(54C-GAL4) does not result in LD accumulation.
(D) Quantification of LD abundance.
Data are represented as mean ± SEM. See also
Figure S5.Lipid Peroxidation in Glial Cells Affects the Demise of
Neurons
LD accumulation occurs early and disappears by the time the
features of ND become more apparent (Figure S2C). To demon-
strate that the lipases reduce the formation of LD, we assessed
the loss of LD upon overexpression of lipases in the eye at day 1.
Overexpression of the lipases significantly reduces LD formation
(Figures 6A a–i and 6C). To assess the specific cellular require-
ments, we determined whether LD accumulation in glia induced
by knockdown of Marf, Aats-met or ND42 (Figure 4) is sup-
pressed by co-expression with Lip4 in neurons. Neuronal
expression of Lip4 suppresses LD accumulation in glia (Figures
6B a–c and quantified in 6D) and ND (Figures S6E and S6F).
Is expressing lipases in glia sufficient to reduce LD and delay
ND? A knockdown of Marf and ND42 (Rh-ND42 RNAi and Rh-
Marf RNAi) in neurons and overexpression of Lip4 or brummerCell 160, 177–190in glia lowers LD accumulation and delays
ND (Figures 6B d–I and Figures S6G and
S6H). In summary, reducing lipid load in
neurons or glia reduces LD accumulation
(Figures 6D and 6E) and delays ND. Note
that with elav-GAL4 or Rh promoter
driven knockdowns of ND42 or Marf,
the onset of ND is significantly delayed
compared to the ND observed in mutant
clones. Finally, reducing lipid load in
both cell types seems more potent in de-
laying ND than reducing lipid load in each
cell type separately.
Since LD formation alone is not suffi-
cient to induce ND (Figures 4C and S5B),
and since levels of ROS are elevated in
mutants, we explored whether accumu-
lated lipids are peroxidated. Lipids can
be peroxidated in presence of ROS and
mediate cellular stress (Niki, 2009; Reed,
2011). To visualize peroxidated lipids,
staining with BODIPY 581⁄591 C11 re-
vealed an abundance of peroxidatedlipids when compared to controls that do not exhibit LD accumu-
lations (Figure 6F). Furthermore, as neuronal overexpression of
SREBP leads to LD accumulation but not ND, we assessed lipid
peroxidation in animals overexpressing SREBP and observed no
difference compared to controls (Figure 6G). Finally, neuronal
knockdown of ND42 results in LD accumulation and peroxidated
lipids. However, this peroxidation is reduced when lipases are
expressed neuronally (Figure 6H). Hence, these data show that
LD accumulation alone is insufficient to cause ND, and ROS is
required in conjunction with LD accumulation to promote ND.
Ndufs4/ Mice Exhibit Glial LD Accumulation and
Neurodegeneration that Is Significantly Ameliorated
with Presymptomatic Antioxidant Treatment
We hypothesized that mitochondrial defects in vertebrates may
also lead to LD accumulation in glia, as mitochondrial genes as, January 15, 2015 ª2015 Elsevier Inc. 183
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Figure 5. Reduction of LD Accumulation Restores Rhabdomere Integrity and Partially Suppresses Neurodegeneration
(A) a–c, Phalloidin staining of whole-mount retina of 1-day-old sicily,Marf, and Aats-metmutant clones exhibit mostly intact rhabdomeres at this early stage. d–f,
Upon aging, sicily (5d),Marf (5d), and Aats-met (10d) mutant clones show obvious signs of degeneration. g–i, animals fed with 40 mg/ml of AD4 exhibit more intact
rhabdomeres after aging for all three mutants. j–l, Reducing LD accumulation by overexpression of hSOD1, or m–r, one copy of JNK or SREBP all partially restore
rhabdomere integrity after aging based on phalloidin staining. s–x, The expression of lipases (brummer and Lip4) in the mutant background also delays
degeneration compared to mutant clones alone.
(B) Quantification of rhabdomere numbers after aging show that expression of hSOD1, feeding AD4 and removing one copy of JNK or SREBP restores rhab-
domere integrity.
(C) Quantification of rhabdomere numbers after aging shows that expression of both brummer and Lip4 significantly restore the number of photoreceptors in all
three mutant backgrounds. Data are represented as mean ± SEM. Significance was calculated compared to controls (*p < 0.05, **p < 0.005, ***p < 0.0005). See
also Figure S6.well as JNK and SREBP are conserved. A mouse model has
been generated which permits modeling of Leigh syndrome by
removing a mitochondrial Complex I subunit, Ndufs4 (Quintana184 Cell 160, 177–190, January 15, 2015 ª2015 Elsevier Inc.et al., 2012; Quintana et al., 2010; Kruse et al., 2008). Mutant
Ndufs4 mice develop normally but exhibit signs of encephalo-
myopathy at postnatal day 30 (P30) and eventually die from
breathing defects around P50. These mice develop brain lesions
similar to those in Leigh syndrome patients. The KO animals also
exhibit reduced activity in Complex I and oxidative stress (Quin-
tana et al., 2012; Assouline et al., 2012).
To determine whether LD accumulate in Ndufs4 KO mice
(Ndufs4/), we systematically profiled the brain with neutral lipid
stains (20 mm coronal sections from the olfactory bulb to the
brain stem) of presymptomatic (P23), mid (P35) and late-stage
(>P50) mice along with gender and age-matched controls. We
observed an abundance of LD in the olfactory bulb (OB) and
vestibular nucleus (VN) of P23 brain slices (Figures 7A a–d and
S7C). We also observed mild LD accumulation in the periaque-
ductal gray, cerebellum, dorsal motor nucleus, vagus and abdu-
cens nuclei of mutant brains that are not observed in controls
(data not shown). As quantified in Figures 7B and 7C, there is
an abundance of LDs in the VN of presymptomatic brains but
LDs progressively disappear in P34 and P50 mice. We also
observed lesions at P34 and >P50 in the areas where LDs accu-
mulated at P23 (Figures S7A and S7B). Aside from the VN, LDs
also accumulate in theOB of presymptomatic animals. However,
unlike in the VN, accumulations in the OB persist throughout the
lifespan of the these mice, perhaps of newborn neurons in this
region (Ming andSong, 2011). Interestingly, the areas of the brain
with LD accumulation at P23 (VN and theOB) do not exhibit other
obvious pathological phenotypes at this time. However, at P34,
and especially at P50, the VN and the OB are the main affected
regions by lesions and gliosis previously described in Quintana
et al. (2012). These data show that LD accumulation precede
physical and histological evidence of ND in mice. In addition,
triglyceride (TAG) levels in OB of early-, mid- and late-stage
Ndufs4/ mice progressively increase (Figure 7D). No differ-
ences in TAG levels were observed in the brainstem, a small
portion of which corresponds to the VN (data not shown).
To determine the cellular specificity of this LD accumulation,
we stained for neutral lipids and glial markers. In the OB and
VN, LD co-localize with the astrocyte andmicroglia markers (Fig-
ure 7A e–h). However, LD are rarely seen at P34 and >P50 mice,
when there are obvious pathological signs, such as reactive as-
trocytes and activated microglia. Hence, LDs accumulate in glia
prior to the onset of the physical signs of ND in the mutants.
We also assessed JNK activation in the OB of WT and P34
Ndufs4/ mice (Figure 7E); a stage at which the highest level
of LD is observed in this area (Figure 7C). Levels of pJNK are
increased in the OB of Ndufs4/ mice (Figure 7E), suggesting
activation of JNK. Finally, neuronal knockdown of fly Ndufs4
(CG12203) via RNAi in neurons also causes LD accumulations
in glia, consistent with our observations in mice (Figures 7F
and 7G).
As the levels of ROS, JNK and LD are elevated, we tested
whether AD4 can delay ND inNdufs4/mice. KOswere injected
intraperitoneally with 150 mg/kg/day from P21 to P28. This short
treatment leads to a delay in onset and reduction in severity of
clinical signs throughout the lifespan of treated mice (Figure 7H).
By P30, the treated KOmice have a significantly delayed latency
to fall in the rotarod assay compared to saline treated KO mice
(Figure 7I). Thus, a brief administration of AD4 is sufficient to
delay the onset of ND and motor defects in Ndufs4/ mice,
arguing that increased ROS plays a role in the pathogenesis.DISCUSSION
Here, we show that neuronal mitochondrial defects that lead to
elevated levels of ROS, induce activation of JNK and SREBP,
which in turn elevate lipid synthesis in neurons and formation
of LD in glial cells. These LDs contribute to and promote ND
through elevated levels of lipid peroxidation. LDs form in glia
prior to or at the onset of the appearance of obvious degenera-
tive histological features in Drosophila and mice. Reducing the
number and size of LD pharmacologically or genetically delays
ND in the fly. To our knowledge, this is the first indication that
SREBP, lipid droplet biogenesis, and lipid metabolism play a
role in the pathogenesis of several neurodegenerative diseases.
A growing body of evidence points to the importance of glial
health and function in nervous system energy metabolism and
homeostasis (Be´langer et al., 2011). Nevertheless, given the
number and prevalence of different types of neurodegenerative
diseases, very few reports have documented the presence of
LDs in either neuron or glia in patients and in animal models.
LD accumulation in the brain has been reported in cells that
line the ventricles in the globus pallidus and substantia nigra in
mutant mice lacking both subunits of the liver X receptor
(Wang et al., 2002), apolipoprotein E (Mato et al., 1999), or a
peroxisomal biogenesis factor (Pex5) (Hulshagen et al., 2008).
In addition, in vitro studies using immortalized cell lines and ex-
plants show that LDmay form and accumulate in glia under con-
ditions of nutrient deprivation or lipopolysaccharide induced
stress (Cabodevilla et al., 2013; Bozza and Viola, 2010). How-
ever, LDs have not been shown to play an active role in neuro-
degenerative processes. Furthermore, LD accumulation has
not been reported in patients with or animal models of Leigh syn-
drome (NDUFS4/Ndufs4, NDUFAF6/sicily), CMT-2A2 or HMSN6
(MFN2/Marf), and ARSAL (MARS2/Aats-met) (Assouline et al.,
2012; McKenzie et al., 2011; Pagliarini et al., 2008; Boaretto
et al., 2010; Bayat et al., 2012; Thiffault et al., 2006). The lack
of neuropathological reports of LDs in animal models or in pa-
tients with NDmay be attributed to the fact that LD accumulation
is transient and mostly occur during presymptomatic stages of
the disease.
Although these genes/mutants are implicated in very different
mitochondrial processes, they exhibit a common phenotype of
elevated levels of ROS, leading to LD accumulation. Similar
morphological changes of glia have been reported under stress
conditions (Boche et al., 2013; Pekny and Nilsson, 2005). Inter-
estingly, mid- and late-stage Ndufs4/ mice exhibit CNS le-
sions in the same brain regions where the LD accumulate in early
stage animals, showing a strong correlative relationship. Simi-
larly, LD accumulation in Drosophila mutants occurs prior to or
at the onset of physical signs of ND. Importantly, the delivery
of AD4 is able to significantly ameliorate LD accumulation in
Drosophila and delay the onset of ND in flies and mice. Hence,
the molecular mechanisms underlying these phenotypes are
likely to be conserved between these species and potentially
also in higher organisms.
In the clinical setting, the prescription of antioxidants toward
treatment of neurodegenerative diseases has been tested
repeatedly on patients with neurodegenerative disorders (Gala-
sko et al., 2012; Gilgun-Sherki et al., 2001; Gandhi and Abramov,Cell 160, 177–190, January 15, 2015 ª2015 Elsevier Inc. 185
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Figure 6. Lipid Peroxidation in Glial Cells Affects the Demise of Neurons
(A) a–i, Nile Red staining of whole-mount retina show that overexpression of brummer and Lip4 in the visual system reduces LD accumulations in sicily,Marf, and
Aats-met mutant clones.
(B) a–c, Neuronal expression of lipases and knockdown of Marf, Aats-met and sicily also reduces LD accumulation in the glia. Flies with elav-GAL4 mediated
knockdown of the RNAis alone were raised at 18C (efficient RNAi leads to high percentage of death) and flies expressing Lip4 and RNAi were raised at 25C.d–i,
Rh-ND42 and Marf RNAi in the neurons results in glial LD accumulation. Expression of brummer and Lip4 in the glia (54C-GAL4) reduces the formation of LD
accumulation.
(legend continued on next page)
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2012), without compelling results. The LD accumulation pheno-
type in our mutants occurs prior to histopathological and
physical signs of ND. A brief period of AD4 delivery prior to the
onset of symptoms in mutant mice is effective in delaying
onset of clinical signs. Thus, therapy with an effective antioxidant
that penetrates the blood-brain barrier should be started early
and sustained over long periods. In addition, pharmacological
manipulation of JNK or lipid levels in the brain may serve as a po-
tential therapy to delay the onset of ND. However, similar to anti-
oxidant treatment, this may need to be administered at an early
stage. Hence, early identification of potential ROS related neuro-
logical disease based on genetic/genomic diagnosis or by bio-
markers may be critical. Since LD accumulation is one of the
earliest presymptomatic changes that occurs in the nervous sys-
tem, detection of LD itself or changes in neurometabolism may
be a promising biomarker.
In summary, we provide evidence for the role of altered lipid
metabolism and a neuron-glia interplay that promotes ND. In
some mitochondrial mutants, we observe an upregulation of
SREBP as well as lipid biogenesis and glial LD formation.
The accumulation of LD is not sufficient to promote the ND
process itself. However, in the presence of ROS the accumu-
lated lipids are peroxidated and promote ND, possibly by
promoting the release of lipids from LD, elevating the cyto-
plasmic load, and causing a progressive loss of LD. Hence,
the synergistic effects of increased lipid synthesis and/or LD
accumulation in combination with elevated ROS and lipid
peroxidation promote ND. Finally, we show that LD accumu-
lation occurs at the onset or precedes ND in flies and mice,
suggesting that LD and changes in lipid metabolism in the
nervous system may be a promising biomarker to identify
brain regions susceptible to but not yet exhibiting symptoms
of ND.
EXPERIMENTAL PROCEDURES
Lipid Droplet Staining
For whole-mount staining of fly retinas, heads were dissected in cold PBS and
fixed in 3.7% formaldehyde for 1 hr. Subsequently, the retinas were dissected
and fixed for an additional 30 min. Retinas were rinsed several times with 13
PBS and incubated for 10 min at 1:1,000 dilution of PBS with 1 mg/ml Nile Red
(Sigma) or BODIPY493/503 (Life Technologies). Subsequently, tissues were
rinsed with PBS and immediately mounted with Vectashield (Vector Labs)
for same-day imaging. Images were obtained with a Zeiss LSM 510
microscope.
For LD staining in the CNS, mice were perfused transcardially with 4% para-
formaldehyde. Brains were extracted and post-fixed in the same fixative over-
night at 4C and then dehydrated in sucrose. They were then embedded
in OCT (Tissue-Tek) and cryosectioned at 20 mm per slice. Slides were
submerged in 13 PBS for 10 min and then incubated for 10 min in Nile Red/
BODIPY as above. Subsequently, the slides were washed twice with 13(C) Quantification of (A).
(D) Quantification of (B a–c), Significance was calculated compared to Figure 4A
(E) Quantification of (B d–i).
(F) a and e. Measurement of peroxidated lipids shows basal level of peroxidate
mutant clones exhibit elevated levels of peroxidated lipids.
(G) Neuronal overexpression of SREBP does not result in elevated levels of pero
(H) Neuronal RNAi knockdown of ND42 results in elevated levels of peroxidated lip
as mean ± SEM. Significance was calculated compared to controls. (*p < 0.05, *PBS and immediately covered with Vectashield mounting medium with DAPI
(Vector Labs) for same-day imaging.
Lipid Peroxidation
Procedures with C11-BODIPY581/591 were adapted for tissue staining instead
of cell culture as described in (Drummen et al., 2002). BODIPY was solubilized
in 50 ml DMSO and was added to a final concentration of 20 mM in BSA. For live
tissue staining of mutant retinas, whole flies were pinned to Sylgard silicone
elastomer plates and submerged with 1% BSA and BODIPY. Tungsten nee-
dles were used to slice the cuticle around the eye for optimal dye penetration.
Plates were incubated for 30 min at 37C and subsequently rinsed with 13
PBS before the retinas were sliced out, mounted with Vectashield, and imaged
immediately.
Tissue Triglyceride Quantification
Triglyceride levels in OB samples (n = 6 for WT mice, n = 3 for each Ndufs4
mice group) were determined using the PicoProbe Triglyceride Quantification
Assay Kit (Abcam) according to manufacturer’s directions. Wild-type mice
included age-matched controls.
AD4 Administration
Control and KO mice were administered i.p. daily for 7 days with either saline
(CT SAL, n = 11; KOSAL, n = 7) or 150mg/kg AD4 (KOAD4, n = 6) from day P21
unil P28.
SUPPLEMENTAL INFORMATION
Supplemental Information includes Extended Experimental Procedures and
seven figures and can be found with this article online at http://dx.doi.org/
10.1016/j.cell.2014.12.019.
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Figure 7. LD Accumulation Is Present in the
Astrocytes and Microglia of Ndufs4/Mice
Prior to Neurodegeneration
(A) a–d 20mm coronal cryosections reveal LD
accumulation in the VN and OB of Ndufs4/mice
compared to control (C57Bl/6). e–h LD accumu-
lates in the astrocytes and microglia of the VN and
OB shown by colocalization with the astrocyte
marker, GFAP and the microglia marker, Iba1.
(B) LD accumulation in the VN is high in the P23
mutants but decreases in number in the P34 and
>P50 mutants.
(C) In the OB, LD accumulation occurs in the P23
mutants and increases in number in the P34 and
>P50 animals.
(D) Ndufs4/ exhibit elevated triglyceride (TAG)
levels in the OB in an age-dependent manner.
(E) pJNK is increased in the mutants. Right panels
show the quantification of the immunoblots.
(F) Neuronal knockdown of dNdufs4 (CG12203)
leads to LD accumulation in the glia, while glial
knockdown results in no LD accumulation. (*p <
0.05, **p < 0.005, ***p < 0.0005).
(G) Quantification of F.
(H and I) 7 day administration of AD4 in P21 ani-
mals via IP injection at 150 mg/kg shows treated
mutant animals with improved clinical signs
(body weight loss, hypotonia, ataxia, piloerection,
clasping, gasping, paralysis, tremor) upon aging
(H) and performing at a comparable level as con-
trol while mutants treated with saline show pro-
gressive decline in motor performance (I). (*p <
0.05 KO SAL versus KO AD4, two-way ANOVA).
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